Literature DB >> 4528388

A neonatal complication of maternal leukaemia treated with 6-mercaptopurine.

J B McConnell, R Bhoola.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4528388      PMCID： PMC2495383          DOI： 10.1136/pgmj.49.569.211

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  6 in total

1.  PASSAGE OF LEUKEMIC CELLS ACROSS THE PLACENTA.

Authors:  P G RIGBY; T A HANSON; R S SMITH
Journal:  N Engl J Med       Date:  1964-07-16       Impact factor: 91.245

2.  The effect of 6-mercaptopurine on the rat fetus and on reproduction of the rat.

Authors:  J B THIERSCH
Journal:  Ann N Y Acad Sci       Date:  1954-12-06       Impact factor: 5.691

3.  Acute leukemia and pregnancy.

Authors:  E P FRENKEL; M C MEYERS
Journal:  Ann Intern Med       Date:  1960-10       Impact factor: 25.391

4.  Acute granulocytic leukemia in pregnancy: report of four cases, with apparent acceleration by prednisone in one.

Authors:  H ROTHBERG; M E CONRAD; R G COWLEY
Journal:  Am J Med Sci       Date:  1959-02       Impact factor: 2.378

5.  Pregnancy in acute leukaemia treated with 6-mercaptopurine.

Authors:  C MERSKEY; W RIGAL
Journal:  Lancet       Date:  1956-12-15       Impact factor: 79.321

6.  Acute leukemia in pregnancy.

Authors:  B A Hoover; H R Schumacher
Journal:  Am J Obstet Gynecol       Date:  1966-10-01       Impact factor: 8.661
  6 in total
  2 in total

1.  Third trimester chemotherapy and neonatal hematopoiesis.

Authors:  J M Meador; S A Armentrout; L M Slater
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  A High Throughput Approach to Reconstruct Partial-Body and Neutron Radiation Exposures on an Individual Basis.

Authors:  Igor Shuryak; Helen C Turner; Jay R Perrier; Lydia Cunha; Monica Pujol Canadell; Mohammad H Durrani; Andrew Harken; Antonella Bertucci; Maria Taveras; Guy Garty; David J Brenner
Journal:  Sci Rep       Date:  2020-02-19       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.